| CATS | Canadian American Ticlopidine Study |
|---|---|
| HCL | hairy-cell leukemia; human cultured lymphoblasts |
| HCl | hydrogen chloride |
| Apo | Apomorphine HCl |
|---|---|
| HCL | Hairy Cell Leukaemia |
| DPPE | N,N-Diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine.HCl |
| Gu.HCl | guanidinium chloride |
| Gdn-HCl | guanidinium hydrochloride |
| ticlopidine | <chemical> 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine. Ticlopidine is an effective inhibitor of platelet aggregation. The drug has been found to significantly reduce infarction size in acute myocardial infarcts and is an effective antithrombotic agent in arteriovenous fistulas, aorto-coronary bypass grafts, ischemic heart disease, venous thrombosis, and arteriosclerosis. Pharmacological action: fibrinolytic agent, platelet aggregation inhibitors. Chemical name: Thieno(3,2-c)pyridine, 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydro- (12 Dec 1998) |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
ÇÏ¿øÆ¼Å¬·ÎÇǵòÁ¤100mg - »õâ
|
ÇÏ¿øÁ¦¾à |
A25850401 | Ticlopidine HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Ƽ³¯ÇÉÁ¤100mg - »õâ
|
ÇϳªÁ¦¾à |
A20450491 | Ticlopidine HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
ƼÇÉÁ¤100mg - »õâ
|
°æµ¿Á¦¾à |
A17650621 | Ticlopidine HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
À¯À¯Å©¸®µåÁ¤100mg - »õâ
|
À¯À¯ |
A02002451 | Ticlopidine HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
ƼŬ·Îµ·Á¤100mg - »õâ
|
»ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
A08202161 | Ticlopidine HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
Á¦ÀÏÆÄ³¯µòÁ¤ - »õâ
|
Á¦ÀϾàǰ |
A04201851 | Ticlopidine HCl | Àü¹®ÀǾàǰ | ºñ±Þ¿© |
|
¸¶ÀÌÆÊ¿°»êƼŬ·ÎÇǵòÁ¤100mg - »õâ
|
Çѱ¹¸¶ÀÌÆÊ |
A19601111 | Ticlopidine HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
Æ÷½ºµòÁ¤ - »õâ
|
¾ËÆÄÁ¦¾à |
A23501471 | Ticlopidine HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
Ÿũ·ÐÁ¤250mg - »õâ
|
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à |
A12902641 | Ticlopidine HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
ƼŬ·Îµ·Á¤250mg - »õâ
|
»ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
A08202111 | Ticlopidine HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|